ArticleBritish journal of cancer2015

Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.

S Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.